Table 4.
In vitro findings of baicalein, baicalin, and wogonin on different brain cell types.
Cell types | Baicalein | Baicalin | Wogonin | Reference(s) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Stimulator | Conc. | Effects | Stimulator | Conc. | Effects | Stimulator | Conc. | Effects | ||
Primary rat retinal cells | Ascorbate/FeSO4 | 100 μM | Attenuate oxidative stress-induced ROS | [123] | ||||||
ARPE-19 cells | H2O2; IL-1b | 50 μM; 40 μM | Antioxidation by scavenging ROS; inhibit the expression of MMP-9 and VEGF; suppress IL-6 and IL-8 proinflammatory cytokines | High glucose | 50 μM | Protect ARPE-19 cells from apoptosis through upregulating the release of microRNA-145; anti-inflammation by initiating the regulation of NF-κB and p38MAPK signaling pathways | LPS; IL-1 β | 10 μM or 50 μM; 1–10 μM | Suppress LPS-induced inflammatory responses via the TLR4/NF-κB pathway and protect the tight junctions; inhibit IL-6 and IL-8 via NF-κB pathway suppression; upregulated claudin-1 and ZO-1 | [122, 124, 125, 127] |
HRMEC | High glucose | High glucose | 50 μM | Protect ARPE-19 cells from apoptosis through upregulating the release of microRNA-145; anti-inflammation by initiating the regulation of NF-κB and p38MAPK signaling pathways | [127] |